COMMUNIQUÉS West-GlobeNewswire

Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
30/05/2024
BURLINGAME, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive [...]
Ardelyx, Inc. Reports Employment Inducement Grants
30/05/2024
WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]
Korro to Participate in Upcoming June Investor and Scientific Conferences
30/05/2024
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences: [...]
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications
30/05/2024
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing [...]
Ultragenyx Announces Positive Top-Line Results from Phase 3 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
30/05/2024
Treatment with DTX401 resulted in a statistically significant reduction in daily cornstarch intake at Week 48 (p<0.0001) with maintenance of glucose control Company will host investor call today at 5:00 p.m. ET [...]
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
30/05/2024
CARLSBAD, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), announced today that on May 23, 2024, it received written notice (the “Delist Notice”) from The [...]
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
30/05/2024
CORAL GABLES, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and [...]
Smart for Life to Attend IFT FIRST, the Premier Food Science and Technology Event
30/05/2024
Industry Leader and Board Member Heather Granato to Explore Acquisition and Strategic Partnership Opportunities Setting Stage for SMFL Future Growth and Innovation MIAMI, May 30, 2024 (GLOBE NEWSWIRE) -- Smart for Life [...]
Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company
30/05/2024
PALO ALTO, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors
30/05/2024
We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights. LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT [...]
Ipsen announces the launch of an employee shareholding plan
30/05/2024
Ipsen announces the launch of an employee shareholding plan PARIS, FRANCE, 30 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) today announced the launch of an employee shareholding plan. The fourth transaction in the last [...]
Ipsen annonce le lancement d'une opération d’actionnariat salarié
30/05/2024
Ipsen annonce le lancement d'une opération d’actionnariat salarié PARIS, FRANCE, 30 mai 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY), annonce aujourd’hui le lancement d'une opération d’actionnariat salarié. Cette 4 ème [...]
OSE Immunotherapeutics Provides Business and Corporate Update
30/05/2024
OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months: New strategic partnership with AbbVie for OSE-230, a novel preclinical potential first- [...]
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société
30/05/2024
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société Trois accords pharmaceutiques signés au cours des trois derniers mois : Un nouveau partenariat stratégique avec [...]
Partnership with Key Opinion Leaders and successful trainings
30/05/2024
Press release Ecully, May 30, 2024 – 6 p.m. SPINEWAY organizes surgical training sessions in the use of ESP and KAPHORN implants The Spineway Group, a specialist in innovative implants for the treatment of severe spine [...]
Partenariat et formations chirurgiens
30/05/2024
Communiqué de presse Ecully, le 30 mai 2024 – 18h SPINEWAY organise des sessions de formation chirurgicale à l’utilisation des implants ESP et KAPHORN Le groupe Spineway spécialiste des implants innovants pour le [...]
L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of a European circular economy
30/05/2024
L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of a European circular economy CARBIOS, L’OCCITANE en Provence and Pinard Beauty Pack join forces to establish an [...]
L’OCCITANE en Provence et CARBIOS présentent un flacon en PET issu du recyclage enzymatique, fruit d’une filière européenne d’économie circulaire
30/05/2024
L’OCCITANE en Provence et CARBIOS présentent un flacon en PET issu du recyclage enzymatique, fruit d’une filière européenne d’économie circulaire CARBIOS, L’OCCITANE en Provence et Pinard Beauty Pack s’unissent pour la [...]
Spectral Medical Inc. Announces Closing of Approximately C$8.5 Million Convertible Notes Financing
30/05/2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES [...]

Pages